(Bloomberg) -- Shares of consumer-products company Kenvue Inc. rose the most in two months after activist investor Starboard Value took a stake in the...
-- Shares of consumer-products company Kenvue Inc. rose the most in two months after activist investor Starboard Value took a stake in the Tylenol maker with an eye toward making changes to boost the company’s stock price.Starboard hasn’t disclosed its stake in Kenvue — spun out of Johnson & Johnson last year — or what issues it aims to tackle, but a person familiar with the matter described it as “sizable.
The activist thinks Kenvue has some of the best consumer brands in the industry but its shares have underperformed the broader market, according to The Wall Street Journal, which earlier reported the news, citing unidentified people familiar with the matter.Other Kenvue brands include Aveeno, Band-Aid, Zyrtec, Neosporin and Neutrogena. Health and beauty make up about 28% of the Skillman, New Jersey-based company’s business, and its performance in that area has been lagging behind peers’.
The reversible top-seller that'll keep you warm on chilly evenings is 'like a hug from a gentle cloud warmed by the sun.'We take our annual trip too close to the sun, where the defending champions could be even better this season.
France's Transport Minister François Durovray is expected to meet with cycling associations on Monday after a cyclist in Paris was allegedly deliberately run over by a motorist following a dispute.The tragedy has reignited a national debate on road safety and cyclist protection. The French transport minister is expected to meet with cycling associations on Monday following the death of a cyclist in Paris after a dispute with a driver.
Bloomberg Activist Investor Johnson & Johnson Kenvue
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Kenvue stock jumps on reports of Starboard Value's stakeActivist investor Starboard Value, which in recent months has taken stakes in coffee chain Starbucks (SBUX) and pharmaceutical giant Pfizer (PFE), has set...
Read more »
Pfizer CEO plans to meet activist investor Starboard Value, FT reportsPfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing people familiar with the matter...
Read more »
Activist investor Starboard Value takes $1 billion stake in Pfizer, WSJ reportsActivist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the U.S. drug giant to make changes to turn its performance around...
Read more »
Activist Investor Starboard Takes $1 Billion Stake in Pfizer Seeking TurnaroundStarboard Value, an activist investor, has acquired a significant stake in Pfizer and aims to revitalize the pharmaceutical giant. The firm has reached out to former Pfizer executives Ian Read and Frank D'Amelio for assistance, who have expressed interest in contributing to the turnaround efforts.
Read more »
Pfizer: Starboard Value pushes for investigation of boardPharmaceutical giant Pfizer (PFE) is butting heads with activist investor Starboard Value, as Starboard demands an investigation into the actions of Pfizer's...
Read more »
Pfizer and Starboard Value, Tesla Robotaxi Day: Market Domination OvertimeOn today's episode of Market Domination Overtime, hosts Julie Hyman and Josh Lipton delve into the top stories following Thursday's market close.This...
Read more »